Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 3
2003 2
2004 3
2007 4
2008 3
2009 4
2010 6
2011 7
2012 11
2013 12
2014 11
2015 10
2016 12
2017 10
2018 13
2019 16
2020 16
2021 23
2022 15
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Glucocorticoid-based pharmacotherapies preventing PTSD.
Florido A, Velasco ER, Monari S, Cano M, Cardoner N, Sandi C, Andero R, Perez-Caballero L. Florido A, et al. Among authors: cardoner n. Neuropharmacology. 2023 Feb 15;224:109344. doi: 10.1016/j.neuropharm.2022.109344. Epub 2022 Nov 17. Neuropharmacology. 2023. PMID: 36402246 Free article. Review.
Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders.
Segal A, Parkes L, Aquino K, Kia SM, Wolfers T, Franke B, Hoogman M, Beckmann CF, Westlye LT, Andreassen OA, Zalesky A, Harrison BJ, Davey CG, Soriano-Mas C, Cardoner N, Tiego J, Yücel M, Braganza L, Suo C, Berk M, Cotton S, Bellgrove MA, Marquand AF, Fornito A. Segal A, et al. Among authors: cardoner n. Nat Neurosci. 2023 Sep;26(9):1613-1629. doi: 10.1038/s41593-023-01404-6. Epub 2023 Aug 14. Nat Neurosci. 2023. PMID: 37580620 Free PMC article.
Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data.
Efthimiou O, Taipale H, Radua J, Schneider-Thoma J, Pinzón-Espinosa J, Ortuño M, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Tanskanen A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, Tiihonen J, Luykx JJ. Efthimiou O, et al. Among authors: cardoner n. Lancet Psychiatry. 2024 Feb;11(2):102-111. doi: 10.1016/S2215-0366(23)00366-8. Epub 2024 Jan 9. Lancet Psychiatry. 2024. PMID: 38215784
Structural brain correlates in major depression, anxiety disorders and post-traumatic stress disorder: A voxel-based morphometry meta-analysis.
Serra-Blasco M, Radua J, Soriano-Mas C, Gómez-Benlloch A, Porta-Casteràs D, Carulla-Roig M, Albajes-Eizagirre A, Arnone D, Klauser P, Canales-Rodríguez EJ, Hilbert K, Wise T, Cheng Y, Kandilarova S, Mataix-Cols D, Vieta E, Via E, Cardoner N. Serra-Blasco M, et al. Among authors: cardoner n. Neurosci Biobehav Rev. 2021 Oct;129:269-281. doi: 10.1016/j.neubiorev.2021.07.002. Epub 2021 Jul 10. Neurosci Biobehav Rev. 2021. PMID: 34256069 Review.
Sex-specifics of ECT outcome.
Blanken MAJT, Oudega ML, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, Van Diermen L, Birkenhager T, Schrijvers D, Redlich R, Dannlowski U, Heindel W, Coenjaerts M, Nordanskog P, Oltedal L, Kessler U, Frid LM, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Bolwig T, Emsell L, Sienaert P, Bouckaert F, Abbott CC, Péran P, Arbus C, Yrondi A, Kiebs M, Philipsen A, van Waarde JA, Prinsen E, van Verseveld M, Van Wingen G, Ten Doesschate F, Camprodon JA, Kritzer M, Barbour T, Argyelan M, Cardoner N, Urretavizcaya M, Soriano-Mas C, Narr KL, Espinoza RT, Prudic J, Rowny S, van Eijndhoven P, Tendolkar I, Dols A. Blanken MAJT, et al. Among authors: cardoner n. J Affect Disord. 2023 Apr 1;326:243-248. doi: 10.1016/j.jad.2022.12.144. Epub 2023 Jan 9. J Affect Disord. 2023. PMID: 36632848
Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Argyelan M, et al. Among authors: cardoner n. Mol Psychiatry. 2023 Nov 20. doi: 10.1038/s41380-023-02318-2. Online ahead of print. Mol Psychiatry. 2023. PMID: 37985787
Amygdala where art thou?
Fullana MA, Albajes-Eizagirre A, Soriano-Mas C, Vervliet B, Cardoner N, Benet O, Radua J, Harrison BJ. Fullana MA, et al. Among authors: cardoner n. Neurosci Biobehav Rev. 2019 Jul;102:430-431. doi: 10.1016/j.neubiorev.2018.06.003. Epub 2018 Jun 7. Neurosci Biobehav Rev. 2019. PMID: 29886178 Free article. No abstract available.
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder.
Fagiolini A, Cardoner N, Pirildar S, Ittsakul P, Ng B, Duailibi K, El Hindy N. Fagiolini A, et al. Among authors: cardoner n. Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1715-1723. doi: 10.1080/14656566.2023.2242264. Epub 2023 Aug 7. Expert Opin Pharmacother. 2023. PMID: 37501324 Review.
158 results